1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 54, n° 6
pages 1039-1045 (juin 2006)
Doi : 10.1016/j.jaad.2006.01.041

Treatment of basal cell carcinoma with curettage alone

James O. Barlow, MD, Mark J. Zalla, MD, Amber Kyle, MD, David J. DiCaudo, MD, Katherine K. Lim, MD , James A. Yiannias, MD
From the Department of Dermatology, Mayo Clinic 

Correspondence to: Katherine K. Lim, MD, Department of Dermatology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259.

Scottsdale, Arizona


Although curettage and electrodesiccation (C&E) is widely used to treat basal cell carcinoma, whether electrodesiccation improves outcome is unknown.


We sought to compare cure rates of curettage alone with those of C&E.


We conducted a retrospective records review of patients treated with curettage alone at 5-year follow-up or longer that extracted data about tumor location, size, histologic subtype, biopsy specimen margin involvement, and recurrence, as well as data about the medical history of patients treated in a dermatology clinic in a tertiary-care academic medical institution.


Biopsy-proven tumors (302) amenable to treatment with C&E and treated by a single investigator with curettage alone had a 5-year cure rate of 96.03%, with minimal complications (hypopigmentation, scarring). Tumors involving more than 50% of the deep edge of the shave biopsy specimen had an increased risk of recurrence.


This is a retrospective study based on historic controls.


For nonaggressive basal cell carcinoma, curettage alone has a cure rate similar to the published rates for C&E.

The full text of this article is available in PDF format.

 Drs Zalla and Kyle are currently in private practice in Florence, Ky, and Torrance, Calif, respectively.
Funding sources: None.
Conflicts of interest: None identified.
Reprints not available from the authors.

© 2006  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline